These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 38566994)

  • 1. Proteome-wide Mendelian randomization identifies therapeutic targets for ankylosing spondylitis.
    Zhao W; Fang P; Lai C; Xu X; Wang Y; Liu H; Jiang H; Liu X; Liu J
    Front Immunol; 2024; 15():1366736. PubMed ID: 38566994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PTGES2 and RNASET2 identified as novel potential biomarkers and therapeutic targets for basal cell carcinoma: insights from proteome-wide mendelian randomization, colocalization, and MR-PheWAS analyses.
    Han QJ; Zhu YP; Sun J; Ding XY; Wang X; Zhang QZ
    Front Pharmacol; 2024; 15():1418560. PubMed ID: 39035989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteome-wide mendelian randomization identifies therapeutic targets for nephrolithiasis.
    Wang L; Li KP; Chen SY; Wan S; Li XR; Yang L
    Urolithiasis; 2024 Sep; 52(1):126. PubMed ID: 39237840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigating potential novel therapeutic targets and biomarkers for ankylosing spondylitis using plasma protein screening.
    You W; Lin Y; Liu M; Lin Z; Ye R; Zhang C; Zeng R
    Front Immunol; 2024; 15():1406041. PubMed ID: 39185422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic associations in ankylosing spondylitis: circulating proteins as drug targets and biomarkers.
    Zhang Y; Liu W; Lai J; Zeng H
    Front Immunol; 2024; 15():1394438. PubMed ID: 38835753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma proteins and psoriatic arthritis: a proteome-wide Mendelian randomization study.
    Zhao H; Zhou Y; Wang Z; Zhang X; Chen L; Hong Z
    Front Immunol; 2024; 15():1417564. PubMed ID: 39026678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of novel protein biomarkers and therapeutic targets for ankylosing spondylitis using human circulating plasma proteomics and genome analysis.
    Zhou Z; Liu C; Feng S; Chen J; Chen T; Zhu J; Wu S; Zhou C; Huang C; Xue J; Qin X; Zhan X
    Anal Bioanal Chem; 2024 Nov; 416(28):6357-6366. PubMed ID: 39254691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteome-Wide Mendelian Randomization and Colocalization Analysis Identify Therapeutic Targets for Knee and Hip Osteoarthritis.
    Zou M; Shao Z
    Biomolecules; 2024 Mar; 14(3):. PubMed ID: 38540773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteome-wide Mendelian randomization identifies potential therapeutic targets for nonalcoholic fatty liver diseases.
    Li J; Ma X; Yin C
    Sci Rep; 2024 May; 14(1):11814. PubMed ID: 38782984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential therapeutic targets for membranous nephropathy: proteome-wide Mendelian randomization and colocalization analysis.
    Su Z; Wan Q
    Front Immunol; 2024; 15():1342912. PubMed ID: 38707900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systematic proteome-wide Mendelian randomization using the human plasma proteome to identify therapeutic targets for lung adenocarcinoma.
    Zhang L; Xiong Y; Zhang J; Feng Y; Xu A
    J Transl Med; 2024 Apr; 22(1):330. PubMed ID: 38576019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mendelian randomization and genetic colocalization infer the effects of the multi-tissue proteome on 211 complex disease-related phenotypes.
    Yang C; Fagan AM; Perrin RJ; Rhinn H; Harari O; Cruchaga C
    Genome Med; 2022 Dec; 14(1):140. PubMed ID: 36510323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mendelian randomization analysis identifies druggable genes and drugs repurposing for chronic obstructive pulmonary disease.
    Wang Z; Li S; Cai G; Gao Y; Yang H; Li Y; Liang J; Zhang S; Hu J; Zheng J
    Front Cell Infect Microbiol; 2024; 14():1386506. PubMed ID: 38660492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utilize proteomic analysis to identify potential therapeutic targets for combating sepsis and sepsis-related death.
    Zhang T; Shi Y; Li J; Huang P; Chen K; Yao J
    Front Endocrinol (Lausanne); 2024; 15():1448314. PubMed ID: 39387050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteome-wide Mendelian randomization highlights AIF1 and HLA-DQA2 as targets for primary sclerosing cholangitis.
    Chen L; Zhao Y; Li M; Lv G
    Hepatol Int; 2024 Apr; 18(2):517-528. PubMed ID: 37950809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploration of potential novel drug targets for diabetic retinopathy by plasma proteome screening.
    Yuan W; Xu W; Xu X; Qu B; Zhao F
    Sci Rep; 2024 May; 14(1):11726. PubMed ID: 38778174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel therapeutic targets for primary open-angle glaucoma identified through multicenter proteome-wide mendelian randomization.
    Yuan W; Li J; Gao S; Sun W; Zhao F
    Front Pharmacol; 2024; 15():1428472. PubMed ID: 39221148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phenome-wide Mendelian randomization mapping the influence of the plasma proteome on complex diseases.
    Zheng J; Haberland V; Baird D; Walker V; Haycock PC; Hurle MR; Gutteridge A; Erola P; Liu Y; Luo S; Robinson J; Richardson TG; Staley JR; Elsworth B; Burgess S; Sun BB; Danesh J; Runz H; Maranville JC; Martin HM; Yarmolinsky J; Laurin C; Holmes MV; Liu JZ; Estrada K; Santos R; McCarthy L; Waterworth D; Nelson MR; Smith GD; Butterworth AS; Hemani G; Scott RA; Gaunt TR
    Nat Genet; 2020 Oct; 52(10):1122-1131. PubMed ID: 32895551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploring novel drug targets for atopic dermatitis through plasma proteome with genome.
    Wu W; Su H; Chen Z; Wei S
    Arch Dermatol Res; 2024 Aug; 316(8):521. PubMed ID: 39136778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetically Determined Chronic Low-Grade Inflammation and Hundreds of Health Outcomes in the UK Biobank and the FinnGen Population: A Phenome-Wide Mendelian Randomization Study.
    Si S; Li J; Tewara MA; Xue F
    Front Immunol; 2021; 12():720876. PubMed ID: 34386016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.